Cite

HARVARD Citation

    Gao, Y. et al. (2020). Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single‐arm, open‐label, phase 3 trial. Liver international. pp. 2685-2693. [Online]. 
  
Back to record